Center for Health Value Innovation">Center for Health Value Innovation

Kavita Nair, PhD.

Kavita Nair, PhD.

Vice President and Treasurer of the Center for Health Value Innovation

Kavita V. Nair, PhD. is an Associate Professor at the University of  Colorado Denver, School of Pharmacy (UCD, SOP). She has over 15 years experience in the design and evaluation of medication use patterns in secondary databases, pharmacy benefit policies and the direct and indirect costs associated with chronic disease states.

Dr. Nair has been Principal Investigator for studies funded by  the pharmaceutical industry, the Medicare Payment Advisory Commission, and Foundations totaling over $1.7  million dollars with over 30 publications. Examples of her work include examining the  impact of the prescription to OTC switch of Claritin on pharmacy utilization and expenditures with MedImpact of California; examining the impact of consumer driven health plans on pharmacy and medical utilization for Definity Health, examining the  impact of reducing prescription co-pays for brand name diabetic medications on pharmacy and medical utilization patterns and health care expenditures for the State of Colorado and Great West Healthcare, and examining the impact of dosing changes and switching for TNF blockers used for treating rheumatoid arthritis, Crohn’s disease and ulcerative colitis on utilization, expenditures and productivity.

Most recently Dr. Nair is working with a pharmaceutical partner in examining the types of monitoring associated with managing multiple sclerosis and associated drug therapy. Dr. Nair has recent experience in evaluating MTM-based programs with the Part D population as well as the analysis of pharmacy, medical, lab and enrollment data for this population. In 2007, Dr. Nair was awarded a task order by the Medicare Payment Advisory Commission to examine the  impact of the Part D benefit on pharmacy and medical utilization, clinical markers and  expenditures.

In 2002, she designed and implemented a survey of 25,000 members for Anthem Blue Cross Blue Shield of Colorado that examined the impact of three-tier plans on prescription utilization and pharmacy expenditures.